Steve Berman of Hagens Berman LLP will replace David Boies as lead counsel in the suit claiming ACNielsen's anticompetitive practices forced deep losses on Information Resources, Inc. (IRI).

More information about the ACNielsen case will be forthcoming as Hagens Berman develops the case.

Nationally Recognized Law Firm, Hagens Berman LLP, to Serve as Lead Trial Counsel in Antitrust Action Against ACNielsen

CHICAGO, May 12, 2004 - Information Resources, Inc. Litigation Contingent Payment Rights Trust (Ticker Symbol: OTC BB:IRICR.OB) announced today that Information Resources, Inc. has filed a letter with the Court in IRI's antitrust action against ACNielsen (now owned by VNU, N.V.), The Dun & Bradstreet Corp., and IMS International, Inc., seeking leave to allow Steve Berman and other members of the Seattle-based law firm of Hagens Berman LLP to serve as lead trial counsel for IRI in this case. IRI is seeking damages of between $581.6 million and $651.7 million (prior to trebling). Trial is scheduled to begin on April 18, 2005.

Subject to Court approval, Mr. Berman and Hagens Berman will join the law firms of Freeborn & Peters, LLP and Fried Frank Harris Shriver and Jacobson LLP in representing IRI in this action. Both Freeborn & Peters and Fried Frank Harris Shriver and Jacobson have been representing IRI in this case since its inception.

Mr. Berman and Hagens Berman will replace David Boies and the law firm of Boies, Schiller & Flexner LLP as lead trial counsel. The Rights Agents responsible for managing the antitrust litigation on behalf of IRI and the holders of contingent value rights certificates (CVRs) were unable to reach an agreement with Boies, Schiller & Flexner, LLP to continue its representation of IRI on terms that the rights agents believed were in the best interest of IRI and the CVR holders.

Hagens Berman, founded in 1993, is one of the nation's premier firms handling large-scale antitrust and other complex litigation. The firm recently acted as co-lead counsel in the largest antitrust settlement in United States history, settling antitrust claims against Visa and MasterCard for approximately $3 billion in cash and injunctive relief valued by the trial judge in excess of $20 billion. Hagens Berman currently serves as lead plaintiffs' counsel in a massive antitrust class-action lawsuit against the pharmaceutical industry, In re Pharmaceutical Industry Average Wholesale Price Litigation, in which plaintiffs allege violations in the setting of reimbursement rates for several hundred prescription drugs. Steve Berman and Hagens Berman also acted as special assistant attorney general for thirteen states, including Illinois and New York, in the 1998 nationwide tobacco settlement. That landmark agreement required the tobacco companies to pay more than $200 billion dollars in compensation to the states. Steve Berman was named by the National Law Journal as one of the top 100 most influential lawyers in the United States.

"We are pleased to have Steve Berman and Hagens Berman join Freeborn & Peters and Fried Frank in representing IRI in this case," said [RIGHTS AGENT]. "Hagens Berman's extensive experience prosecuting complex cases, and the firm's proven track record of success, especially its very significant recent successes, make it an obvious choice to serve as IRI's lead trial counsel in this case."

Additional information about the lawsuit, the Litigation Trust, and the CVRs trading under IRICR.OB can be found in the disclosure materials filed by the Information Resources, Inc. Litigation Contingent Payment Rights Trust with the Securities and Exchange Commission, including the prospectus dated November 3, 2003 relating to the CVRs and the Litigation Trust's Annual Report on Form 10-K for the year 2003.

This document contains certain forward-looking statements about the Litigation Trust and/or the ACNielsen lawsuit and the CVRs. When used in this document, the words "anticipates", "may", "can", "believes", "expects", "projects", "intends", "likely", and similar expressions as they relate to the Litigation Trust, the ACNielsen lawsuit or the CVRs are intended to identify those assertions as forward-looking statements. In making any such statements, the person making them believes that its expectations are based on reasonable assumptions. However, any such statement may be influenced by factors that could cause actual outcomes and results to be materially different from those projected or anticipated. These forward-looking statements are subject to numerous risks and uncertainties. There are various important factors that could cause actual results to differ materially from those in any such forward-looking statements, many of which are beyond the control of the Litigation Trust including the timing of and any value to be received in connection with the ACNielsen lawsuit and the CVRs. The actual results or performance by the Litigation Trust and the actual proceeds (if any) to be received by the Litigation Trust in respect of the ACNielsen lawsuit or the CVRs, could differ materially from those expressed in, or implied by, these forward-looking statements. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the outcome of the ACNielsen lawsuit or the proceeds to be received.